Preventing Heart Failure Readmission in Patients with Low Socioeconomic Position.


Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
11 2023
Historique:
accepted: 12 09 2023
medline: 29 11 2023
pubmed: 26 9 2023
entrez: 26 9 2023
Statut: ppublish

Résumé

This review aims to summarize the current burden of heart failure (HF) in the United States, specifically in patients with low socioeconomic position (SEP), and synthesize recommendations to prevent HF-related hospital readmissions in this vulnerable population. As treatments have improved, HF-related mortality has declined over time, resulting in more patients living with HF. This has led to an increase in hospitalizations, however, putting excess strain on our healthcare system. HF patients with low SEP are a particularly vulnerable group, as they experience higher rates of hospitalization and readmission compared to their high SEP counterparts. The Hospital Readmission Reduction Program (HRRP) was created to motivate interventions that reduce hospital readmissions across diseases, with HF being a primary target. Numerous readmission prevention efforts have been suggested to target the pre-hospitalization, hospitalization, and post-hospitalization phases, including addressing social determinants of health (SDoH), improving coordination of care, optimizing discharge plans, and improving adherence to follow-up care and medication regimens. Many of these proposed interventions show promise in reducing HF-related readmissions and issues surrounding adequate caregiver support may be particularly important to reduce readmissions among persons in low SEP. Reducing HF-related hospital readmissions is possible, even in vulnerable populations like those with low SEP, but this will require coordinated efforts across the healthcare system and throughout the life course of these patients. Caregiver support is a necessary part of optimized care for low SEP HF patients and future efforts should consider interventions that support these caregivers.

Identifiants

pubmed: 37751036
doi: 10.1007/s11886-023-01960-0
pii: 10.1007/s11886-023-01960-0
pmc: PMC10863623
mid: NIHMS1962343
doi:

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1535-1542

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007055
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Circulation. 2015 May 19;131(20):1796-803
pubmed: 25986448
Oman Med J. 2011 May;26(3):155-9
pubmed: 22043406
Heart. 2016 Nov 15;102(22):1820-1825
pubmed: 27357124
Ann Am Acad Pol Soc Sci. 2017 Jan;669(1):125-145
pubmed: 28413218
J Am Heart Assoc. 2021 Dec 21;10(24):e019706
pubmed: 34873919
Am J Cardiol. 2008 Apr 1;101(7):1016-22
pubmed: 18359324
Eur J Heart Fail. 2021 Jul;23(7):1182-1190
pubmed: 33759308
Circulation. 2022 Feb 22;145(8):e153-e639
pubmed: 35078371
Health Psychol. 2016 Apr;35(4):407-11
pubmed: 27018733
ESC Heart Fail. 2020 Aug;7(4):1688-1699
pubmed: 32383551
Curr Atheroscler Rep. 2021 Jul 26;23(9):55
pubmed: 34308497
NCHS Data Brief. 2015 Dec;(231):1-8
pubmed: 26727546
Curr Probl Cardiol. 2023 Oct;48(10):101795
pubmed: 37207818
J Am Heart Assoc. 2019 Aug 20;8(16):e013148
pubmed: 31422733
J Med Internet Res. 2022 Feb 15;24(2):e32946
pubmed: 35166680
Circ Heart Fail. 2021 Apr;14(4):e008335
pubmed: 33866827
Can J Cardiol. 2010 Aug-Sep;26 Suppl C:8C-13C
pubmed: 20847985
Ann Intern Med. 2018 Apr 17;168(8):577-578
pubmed: 29677265
J Patient Exp. 2015 May;2(1):7-12
pubmed: 28725810
J Community Health. 2017 Oct;42(5):865-871
pubmed: 28315111
Circulation. 2012 Jul 24;126(4):501-6
pubmed: 22825412
Cureus. 2022 Jan 11;14(1):e21123
pubmed: 35165579
J Am Board Fam Med. 2021 May-Jun;34(3):561-570
pubmed: 34088816
Eur J Heart Fail. 2012 Feb;14(2):138-46
pubmed: 22253454
Res Social Adm Pharm. 2016 Mar-Apr;12(2):218-46
pubmed: 26164400
Int J Environ Res Public Health. 2019 May 28;16(11):
pubmed: 31142017
J Manag Care Spec Pharm. 2021 Jul;27(7):924-935
pubmed: 34185554
Atherosclerosis. 2022 Apr;346:82-83
pubmed: 35249764
J Am Heart Assoc. 2023 Feb 7;12(3):e026590
pubmed: 36695317
Circ Res. 2021 May 14;128(10):1421-1434
pubmed: 33983838
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Medicine (Baltimore). 2022 Aug 5;101(31):e29805
pubmed: 35945723
Heart. 2021 Feb;107(3):208-216
pubmed: 33082175
N Engl J Med. 2019 Jun 13;380(24):2289-2291
pubmed: 31091367
Int J Nurs Sci. 2020 Jul 25;7(4):438-445
pubmed: 33195757
Medicine (Baltimore). 2019 Jul;98(27):e16233
pubmed: 31277137
J Community Health Nurs. 2018 Jan-Mar;35(1):28-37
pubmed: 29323941
Patient Prefer Adherence. 2017 Apr 20;11:801-810
pubmed: 28461742
Circulation. 2020 Jun 2;141(22):e864-e878
pubmed: 32349542
J Med Internet Res. 2020 Apr 28;22(4):e17883
pubmed: 32343250
Circ Cardiovasc Qual Outcomes. 2021 Apr;14(4):e006962
pubmed: 33757307
Front Public Health. 2020 Jun 18;8:231
pubmed: 32626678
J Gen Intern Med. 2022 Aug;37(11):2845-2848
pubmed: 35352272
Circ Cardiovasc Qual Outcomes. 2020 Oct;13(10):e006553
pubmed: 32967439
J Cardiovasc Nurs. 2016 Mar-Apr;31(2):121-30
pubmed: 25569150
J Gen Intern Med. 2014 Feb;29(2):283-9
pubmed: 23918162
Circ Heart Fail. 2013 May;6(3):606-19
pubmed: 23616602
Cureus. 2020 Mar 25;12(3):e7420
pubmed: 32351805
Heart. 2021 Feb;107(3):229-236
pubmed: 32769169
Patient Educ Couns. 2018 Mar;101(3):363-374
pubmed: 29102442
Circ Res. 2022 Mar 4;130(5):782-799
pubmed: 35239404

Auteurs

Sydney E Browder (SE)

UNC Gillings School of Global Public Health, Department of Epidemiology, Chapel Hill, NC, USA. sydney_browder@med.unc.edu.

Wayne D Rosamond (WD)

UNC Gillings School of Global Public Health, Department of Epidemiology, Chapel Hill, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH